National Health Investors - NHI Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $59.50
  • Forecasted Upside: 5.11 %
  • Number of Analysts: 4
  • Breakdown:
  • 1 Sell Ratings
  • 2 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$56.61
▲ +0.08 (0.14%)

This chart shows the closing price for NHI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New National Health Investors Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NHI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NHI

Analyst Price Target is $59.50
▲ +5.11% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for National Health Investors in the last 3 months. The average price target is $59.50, with a high forecast of $64.00 and a low forecast of $51.00. The average price target represents a 5.11% upside from the last price of $56.61.

This chart shows the closing price for NHI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 4 contributing investment analysts is to hold stock in National Health Investors. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 7 hold ratings
  • 1 sell ratings
4/11/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 1 sell ratings
7/10/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 1 sell ratings
10/8/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 1 sell ratings
1/6/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 1 sell ratings
4/6/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 1 sell ratings
7/5/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 1 sell ratings
9/3/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 1 sell ratings
10/3/2022

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/26/2022Truist FinancialLower TargetHold$64.00 ➝ $61.00Low
6/22/2022Credit Suisse GroupInitiated CoverageUnderperformLow
6/21/2022BMO Capital MarketsDowngradeOutperform ➝ Market Perform$62.00Low
6/3/2022Capital One FinancialInitiated CoverageOverweight ➝ Overweight$64.00Medium
4/19/2022BMO Capital MarketsLower TargetOutperform$63.00 ➝ $61.00Medium
2/1/2022Credit Suisse GroupInitiated CoverageUnderperform$51.00Medium
1/7/2022BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$68.00High
11/9/2021Capital One FinancialUpgradeEqual Weight ➝ OverweightHigh
9/23/2021Truist FinancialLower TargetHold$71.00 ➝ $64.00Low
7/23/2021Wells Fargo & CompanyLower TargetEqual Weight$74.00 ➝ $72.00Low
6/18/2021BMO Capital MarketsUpgradeUnderperform ➝ Market Perform$71.00High
4/5/2021Wells Fargo & CompanyBoost TargetHold ➝ Equal Weight$66.00 ➝ $74.00Low
3/30/2021Capital One FinancialDowngradeOverweight ➝ Equal Weight$77.00Low
3/23/2021Truist FinancialBoost Target$69.00 ➝ $74.00Low
1/13/2021MizuhoDowngradeNeutral ➝ Underperform$56.00 ➝ $55.00Medium
1/7/2021BMO Capital MarketsDowngradeMarket Perform ➝ Underperform$68.00Low
12/14/2020KeyCorpUpgradeUnderweight ➝ Sector WeightMedium
12/2/2020Berenberg BankDowngradeBuy ➝ HoldLow
9/1/2020Stifel NicolausReiterated RatingHold$63.00High
6/24/2020SunTrust BanksBoost TargetHold$61.00 ➝ $64.00Low
6/17/2020Wells Fargo & CompanyBoost TargetEqual Weight$54.00 ➝ $66.00High
6/8/2020JMP SecuritiesInitiated CoverageMarket PerformHigh
5/22/2020MizuhoDowngradeBuy ➝ Neutral$60.00 ➝ $55.00Medium
5/14/2020KeyCorpLower TargetUnderweight$43.00 ➝ $40.00High
4/23/2020SunTrust BanksLower TargetHold$77.00 ➝ $61.00Low
4/21/2020KeyCorpLower TargetUnderweight$65.00 ➝ $43.00Medium
3/26/2020Wells Fargo & CompanyLower TargetEqual Weight$82.00 ➝ $51.00High
2/5/2020Berenberg BankInitiated CoverageBuy$94.00Medium
1/7/2020BMO Capital MarketsUpgradeUnderperform ➝ Market Perform$74.00 ➝ $82.00Low
12/20/2019MizuhoReiterated RatingBuy$95.00High
2/20/2019SunTrust BanksBoost TargetHold ➝ Neutral$85.00High
2/20/2019BMO Capital MarketsDowngradeMarket Perform ➝ Underperform$78.00Medium
12/20/2018KeyCorpSet TargetSell$65.00High
11/8/2018Cantor FitzgeraldReiterated RatingHold$80.00Low
8/28/2018Wells Fargo & CompanyReiterated RatingHoldLow
8/8/2018Cantor FitzgeraldBoost TargetNeutral ➝ Neutral$75.00 ➝ $80.00Low
8/8/2018SunTrust BanksReiterated RatingHold$79.00Medium
8/7/2018Stifel NicolausSet TargetBuy$83.00Medium
5/31/2018Wells Fargo & CompanySet TargetMarket Perform ➝ Market Perform$68.00 ➝ $75.00Low
5/16/2018Cantor FitzgeraldReiterated RatingNeutralMedium
5/11/2018Capital One FinancialUpgradeEqual Weight ➝ OverweightLow
5/8/2018Cantor FitzgeraldReiterated RatingHold$75.00Medium
4/17/2018KeyCorpLower TargetUnderweight ➝ Sell$70.00 ➝ $60.00Low
3/26/2018BMO Capital MarketsSet TargetHold$70.00Low
2/26/2018MizuhoReiterated RatingHold$70.00High
2/17/2018Stifel NicolausSet TargetBuy$76.00Medium
2/17/2018SunTrust BanksSet TargetHold$70.00Medium
2/16/2018Hilliard LyonsUpgradeNeutral ➝ BuyLow
2/16/2018Cantor FitzgeraldReiterated RatingHold$85.00High
1/22/2018SunTrust BanksSet TargetHold$75.00Low
1/17/2018Cantor FitzgeraldReiterated RatingHold$85.00Low
1/12/2018StephensSet TargetBuy$79.00High
12/19/2017KeyCorpReiterated RatingSector Weight ➝ UnderweightMedium
11/24/2017KeyCorpReiterated RatingHoldN/A
10/23/2017Capital One FinancialInitiated CoverageEqual WeightN/A
10/18/2017BMO Capital MarketsReiterated RatingHold$80.00N/A
10/10/2017SunTrust BanksInitiated CoverageHold$80.00N/A
10/4/2017MizuhoReiterated RatingHold$82.00Low
10/4/2017Stifel NicolausReiterated RatingBuy$82.00Low
(Data available from 10/3/2017 forward)

News Sentiment Rating

0.17 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
3/7/2022
  • 0 very positive mentions
  • 3 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
4/6/2022
  • 3 very positive mentions
  • 10 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
5/6/2022
  • 1 very positive mentions
  • 11 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
6/5/2022
  • 3 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/5/2022
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/4/2022
  • 4 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/3/2022
  • 1 very positive mentions
  • 11 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
10/3/2022

Current Sentiment

  • 1 very positive mentions
  • 11 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
National Health Investors logo
Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Read More

Today's Range

Now: $56.61
Low: $56.25
High: $57.06

50 Day Range

MA: $63.71
Low: $55.31
High: $67.10

52 Week Range

Now: $56.61
Low: $50.22
High: $67.16

Volume

10,680 shs

Average Volume

282,539 shs

Market Capitalization

$2.53 billion

P/E Ratio

38.77

Dividend Yield

6.37%

Beta

0.91

Frequently Asked Questions

What sell-side analysts currently cover shares of National Health Investors?

The following sell-side analysts have issued stock ratings on National Health Investors in the last twelve months: BMO Capital Markets, Capital One Financial Co., Credit Suisse Group AG, StockNews.com, TheStreet, and Truist Financial Co..
View the latest analyst ratings for NHI.

What is the current price target for National Health Investors?

4 Wall Street analysts have set twelve-month price targets for National Health Investors in the last year. Their average twelve-month price target is $59.50, suggesting a possible upside of 5.1%. Capital One Financial Co. has the highest price target set, predicting NHI will reach $64.00 in the next twelve months. Credit Suisse Group AG has the lowest price target set, forecasting a price of $51.00 for National Health Investors in the next year.
View the latest price targets for NHI.

What is the current consensus analyst rating for National Health Investors?

National Health Investors currently has 1 sell rating, 2 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in NHI, but not buy more shares or sell existing shares.
View the latest ratings for NHI.

What other companies compete with National Health Investors?

How do I contact National Health Investors' investor relations team?

National Health Investors' physical mailing address is 222 ROBERT ROSE DRIVE, MURFREESBORO TN, 37129. The real estate investment trust's listed phone number is (615) 890-9100 and its investor relations email address is [email protected] The official website for National Health Investors is www.nhireit.com. Learn More about contacing National Health Investors investor relations.